{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:29:23Z","timestamp":1790044163595,"version":"4.0.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.suc.2024.06.008","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T09:46:12Z","timestamp":1725615972000},"page":"95-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Treatment of Gastric Cancer Carcinomatosis"],"prefix":"10.1016","volume":"105","author":[{"given":"Alicia","family":"Gingrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Manguso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall","family":"Zuckerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.suc.2024.06.008_bib1","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.3748\/wjg.v29.i16.2452","article-title":"Updates on global epidemiology, risk and prognostic factors of gastric cancer","volume":"29","author":"Yang","year":"2023","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.suc.2024.06.008_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2468-1253(19)30328-0","article-title":"The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.suc.2024.06.008_bib3","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1245\/s10434-016-5409-7","article-title":"Yield of staging laparoscopy and lavage cytology for radiologically occult peritoneal carcinomatosis of gastric cancer","volume":"23","author":"Ikoma","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.suc.2024.06.008_bib4","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jamcollsurg.2014.03.062","article-title":"Rates and patterns of recurrence after curative intent resection for gastric cancer: a United States multi-institutional analysis","volume":"219","author":"Spolverato","year":"2014","journal-title":"J\u00a0Am Coll Surg"},{"issue":"3","key":"10.1016\/j.suc.2024.06.008_bib5","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ijc.28373","article-title":"Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors","volume":"134","author":"Thomassen","year":"2014","journal-title":"Int J Cancer"},{"issue":"21","key":"10.1016\/j.suc.2024.06.008_bib6","first-page":"4882","article-title":"The Burden of Peritoneal Metastases from Gastric Cancer: A Systematic Review on the Incidence, Risk Factors and Survival","volume":"10","author":"Rijken","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.suc.2024.06.008_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1245\/s10434-019-07624-0","article-title":"Gastric cancer peritoneal carcinomatosis risk score","volume":"27","author":"Ji","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.suc.2024.06.008_bib8","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1093\/annonc\/mdt401","article-title":"No improvement in median survival for patients with metastatic gastric cancer despite increased use of chemotherapy","volume":"24","author":"Bernards","year":"2013","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.suc.2024.06.008_bib9","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/01.sla.0000143245.28656.15","article-title":"Patterns of initial recurrence in completely resected gastric adenocarcinoma","volume":"240","author":"D'Angelica","year":"2004","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.suc.2024.06.008_bib10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study","volume":"88","author":"Sadeghi","year":"2000","journal-title":"Cancer: Interdisciplinary International Journal of the American Cancer Society"},{"key":"10.1016\/j.suc.2024.06.008_bib11","unstructured":"NCCN Clinical Practice Guidelines in Oncology. Gastric Cancer. 2024. Version 1.2024 - March 7, 2024."},{"issue":"35","key":"10.1016\/j.suc.2024.06.008_bib12","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1200\/JCO.19.01124","article-title":"Individual patient data meta-analysis of the value of microsatellite instability as a biomarker in gastric cancer","volume":"37","author":"Pietrantonio","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"10294","key":"10.1016\/j.suc.2024.06.008_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"issue":"9742","key":"10.1016\/j.suc.2024.06.008_bib14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.suc.2024.06.008_bib15","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/cncr.32868","article-title":"The Chicago Consensus on peritoneal surface malignancies: management of gastric metastases","volume":"126","year":"2020","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.suc.2024.06.008_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s13193-011-0074-6","article-title":"Positive Peritoneal Cytology in Patients with Gastric Cancer: Natural History and Outcome of 291 Patients","volume":"2","author":"Mezhir","year":"2011","journal-title":"Indian Journal of Surgical Oncology"},{"key":"10.1016\/j.suc.2024.06.008_bib17","doi-asserted-by":"crossref","unstructured":"Jacquet P, Sugarbaker PH. Peritoneal-plasma barrier. Peritoneal carcinomatosis: principles of management, 1996. p. 53\u201363.","DOI":"10.1007\/978-1-4613-1247-5_4"},{"issue":"1","key":"10.1016\/j.suc.2024.06.008_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10120-016-0662-9","article-title":"Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis","volume":"20","author":"Kobayashi","year":"2017","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.suc.2024.06.008_bib19","doi-asserted-by":"crossref","DOI":"10.21037\/tgh.2016.08.03","article-title":"Intraperitoneal free cancer cells in gastric cancer: pathology of peritoneal carcinomatosis and rationale for intraperitoneal chemotherapy\/hyperthermic intraperitoneal chemotherapy in gastric cancer","volume":"1","author":"Ji","year":"2016","journal-title":"Translational Gastroenterology and Hepatology"},{"issue":"6 Suppl 9","key":"10.1016\/j.suc.2024.06.008_bib20","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1053\/j.seminoncol.2005.06.002","article-title":"Neoadjuvant chemotherapy, surgery, and adjuvant intraperitoneal chemotherapy in patients with locally advanced gastric or gastroesophageal junction carcinoma: a phase II study","volume":"32","author":"Newman","year":"2005","journal-title":"Semin Oncol"},{"issue":"6","key":"10.1016\/j.suc.2024.06.008_bib21","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3892\/ol.2012.914","article-title":"Adjuvant combined systemic chemotherapy and intraperitoneal chemotherapy for locally advanced gastric cancer","volume":"4","author":"Xue","year":"2012","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.suc.2024.06.008_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jso.20133","article-title":"Preoperative intraperitoneal chemotherapy for patients with serosa-infiltrating gastric cancer","volume":"88","author":"Yano","year":"2004","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.suc.2024.06.008_bib23","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00268-001-0067-7","article-title":"Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial","volume":"25","author":"Yu","year":"2001","journal-title":"World J Surg"},{"issue":"12","key":"10.1016\/j.suc.2024.06.008_bib24","doi-asserted-by":"crossref","first-page":"7244","DOI":"10.1245\/s10434-022-12383-6","article-title":"Don\u2019t Call It a Comeback\u2014HIPEC for Gastric Cancer","volume":"29","author":"Badgwell","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.suc.2024.06.008_bib25","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/bjs.7586","article-title":"Systematic review of intraperitoneal chemotherapy for gastric cancer","volume":"98","author":"Matharu","year":"2011","journal-title":"Journal of British Surgery"},{"issue":"2","key":"10.1016\/j.suc.2024.06.008_bib26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4251\/wjgo.v2.i2.109","article-title":"A\u00a0pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy","volume":"2","author":"Yan","year":"2010","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"10.1016\/j.suc.2024.06.008_bib27","first-page":"29","article-title":"Surgical technology and pharmacology of hyperthermic perioperative chemotherapy","volume":"7","author":"Sugarbaker","year":"2016","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.suc.2024.06.008_bib28","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1245\/s10434-011-1770-8","article-title":"Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination","volume":"18","author":"Fujiwara","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.suc.2024.06.008_bib29","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1200\/JCO.1994.12.5.970","article-title":"Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer","volume":"12","author":"Sautner","year":"1994","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2024.06.008_bib30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s10120-011-0027-3","volume":"14","author":"Miyashiro","year":"2011","journal-title":"Gastric Cancer"},{"issue":"4","key":"10.1016\/j.suc.2024.06.008_bib31","first-page":"269","article-title":"Phase II study of Taxol in patients with advanced gastric carcinoma","volume":"4","author":"Ajani","year":"1998","journal-title":"Cancer J Sci Am"},{"key":"10.1016\/j.suc.2024.06.008_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02993858","article-title":"Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293","volume":"13","author":"Einzig","year":"1996","journal-title":"Med Oncol"},{"issue":"1","key":"10.1016\/j.suc.2024.06.008_bib33","doi-asserted-by":"crossref","first-page":"H26","DOI":"10.1152\/ajpheart.1985.248.1.H26","article-title":"Peritoneal absorption of macromolecules studied by quantitative autoradiography","volume":"248","author":"Flessner","year":"1985","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"75","key":"10.1016\/j.suc.2024.06.008_bib34","first-page":"960","article-title":"Intraperitoneal paclitaxel: a possible impact of regional delivery for prevention of peritoneal carcinomatosis in patients with gastric carcinoma","volume":"54","author":"Kodera","year":"2007","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.suc.2024.06.008_bib35","series-title":"Phase II study of intraperitoneal paclitaxel plus S-1\/paclitaxel for gastric cancer with positive peritoneal cytology: CY-PHOENIX trial","author":"Aizawa","year":"2017"},{"key":"10.1016\/j.suc.2024.06.008_bib36","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s10120-018-0817-y","volume":"21","author":"Takahashi","year":"2018","journal-title":"Gastric Cancer"},{"issue":"19","key":"10.1016\/j.suc.2024.06.008_bib37","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1200\/JCO.2018.77.8613","article-title":"Phase III trial comparing intraperitoneal and intravenous paclitaxel plus S-1 versus cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC trial","volume":"36","author":"Ishigami","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2024.06.008_bib38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Peritoneal Carcinomatosis: Principles of Management"},{"issue":"7","key":"10.1016\/j.suc.2024.06.008_bib39","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ejso.2015.03.231","article-title":"Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis","volume":"41","author":"Coccolini","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.suc.2024.06.008_bib40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1470-2045(15)00553-7","article-title":"Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial","volume":"17","author":"Fujitani","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.suc.2024.06.008_bib41","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial","volume":"18","author":"Yang","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.suc.2024.06.008_bib42","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jso.23633","article-title":"Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial","volume":"110","author":"Rudloff","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.suc.2024.06.008_bib43","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","article-title":"Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy","volume":"17","author":"Glehen","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.suc.2024.06.008_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10120-019-00978-0","article-title":"Peritoneal metastasis in gastric cancer: results from the German database","volume":"23","author":"Rau","year":"2020","journal-title":"Gastric Cancer"},{"issue":"23","key":"10.1016\/j.suc.2024.06.008_bib45","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.18.01688","article-title":"Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis","volume":"37","author":"Bonnot","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.suc.2024.06.008_bib46","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/bjs\/znab200","article-title":"Prognosis of poorly cohesive gastric cancer after complete cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CYTO-CHIP study)","volume":"108","author":"Bonnot","year":"2021","journal-title":"Br J Surg"},{"key":"10.1016\/j.suc.2024.06.008_bib47","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s10120-016-0684-3","article-title":"Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings","volume":"20","author":"Ishigami","year":"2017","journal-title":"Gastric Cancer"},{"issue":"2","key":"10.1016\/j.suc.2024.06.008_bib48","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10120-015-0575-z","article-title":"Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification","volume":"19","author":"Yoshida","year":"2016","journal-title":"Gastric Cancer"},{"issue":"1","key":"10.1016\/j.suc.2024.06.008_bib49","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00464-017-5668-9","article-title":"Lessons learned from a phase II clinical trial of laparoscopic HIPEC for gastric cancer","volume":"32","author":"Badgwell","year":"2018","journal-title":"Surg Endosc"},{"key":"10.1016\/j.suc.2024.06.008_bib50","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1245\/s10434-017-6047-4","article-title":"Phase II trial of laparoscopic hyperthermic intraperitoneal chemoperfusion for peritoneal carcinomatosis or positive peritoneal cytology in patients with gastric adenocarcinoma","volume":"24","author":"Badgwell","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"10.1016\/j.suc.2024.06.008_bib51","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1245\/s10434-020-08968-8","article-title":"Laparoscopic HIPEC for Low-Volume Peritoneal Metastasis in Gastric and Gastroesophageal Adenocarcinoma","volume":"27","author":"Blumenthaler","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2024.06.008_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-14-183","article-title":"GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study","volume":"14","author":"Glehen","year":"2014","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.suc.2024.06.008_bib53","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/bjs.11588","article-title":"Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results","volume":"107","author":"Kaaij","year":"2020","journal-title":"Br J Surg"},{"issue":"7","key":"10.1016\/j.suc.2024.06.008_bib54","doi-asserted-by":"crossref","first-page":"e7790","DOI":"10.2196\/resprot.7790","article-title":"Treatment of peritoneal dissemination in stomach cancer patients with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): rationale and design of the PERISCOPE study","volume":"6","author":"van der Kaaij","year":"2017","journal-title":"JMIR Research Protocols"},{"key":"10.1016\/j.suc.2024.06.008_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5640-2","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)","volume":"19","author":"Koemans","year":"2019","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.suc.2024.06.008_bib56","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1200\/JCO.22.02867","article-title":"Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial","volume":"42","author":"Rau","year":"2024","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.suc.2024.06.008_bib57","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1186\/s12885-019-6125-z","article-title":"Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study","volume":"19","author":"Beeharry","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.suc.2024.06.008_bib58","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1245\/s10434-012-2496-y","article-title":"Perioperative management of patients undergoing cytoreductive surgery combined with heated intraperitoneal chemotherapy for peritoneal surface malignancy: a multi-institutional experience","volume":"19","author":"Bell","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2024.06.008_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2017.03.030","article-title":"The 30-year experience\u2014A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer","volume":"79","author":"Desiderio","year":"2017","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.suc.2024.06.008_bib60","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1245\/s10434-021-09927-7","article-title":"The landmark series: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC) for treatment of gastric cancer metastatic to peritoneum","volume":"28","author":"Dineen","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.suc.2024.06.008_bib61","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00423-021-02137-5","article-title":"Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: experience from a Western tertiary referral center","volume":"406","author":"Rosa","year":"2021","journal-title":"Langenbeck's Arch Surg"},{"issue":"6","key":"10.1016\/j.suc.2024.06.008_bib62","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ejso.2016.09.008","article-title":"Best practice for perioperative management of patients with cytoreductive surgery and HIPEC","volume":"43","author":"Rasp\u00e9","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"8794","key":"10.1016\/j.suc.2024.06.008_bib63","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0140-6736(92)90792-2","article-title":"Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer","volume":"339","author":"Hagiwara","year":"1992","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.suc.2024.06.008_bib64","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1245\/s10434-020-08226-x","article-title":"Phase I Trial of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) with Cisplatin, Mitomycin, and Paclitaxel in Patients with Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology","volume":"27","author":"Blum Murphy","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2024.06.008_bib65","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1245\/s10434-018-07140-7","article-title":"Laparoscopic hyperthermic intraperitoneal chemotherapy is safe for patients with peritoneal metastases from gastric cancer and may lead to gastrectomy","volume":"26","author":"Newhook","year":"2019","journal-title":"Ann Surg Oncol"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003961092400094X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003961092400094X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T05:16:46Z","timestamp":1755494206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003961092400094X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S003961092400094X"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2024.06.008","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Gastric Cancer Carcinomatosis","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2024.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}